Clinical Trial Update: Monocyte Function and Inflammation in Type 1 Diabetes and Its Modulation [Phase 2]

View source ↗

Summary

This Phase 2 trial studied modulation of monocyte function and inflammation in Type 1 diabetes mellitus and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of California, Davis | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED